Manages anxiety disorders. ANDA 84768, held by Barr. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 84768 (Chlordiazepoxide Hydrochloride), held by Barr, was first approved by FDA on Jun 10, 1976, with 26 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Chlordiazepoxide HCl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of chlordiazepoxide HCl capsules in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 10, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride5MG · capsule;oral | Chlordiazepoxide Hydrochloride | RxReference drug |
| Jan 17, 2023 | Supplement 95Labeling · Standard review | Approved | None posted |
| Feb 5, 2021 | Supplement 93Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 89Labeling · Standard review | Approved | None posted |
| Dec 4, 2001 | Supplement 85Manufacturing | Approved | None posted |
| Jun 23, 2000 | Supplement 84Manufacturing | Approved | None posted |
| Jun 23, 2000 | Supplement 83Manufacturing | Approved | None posted |
| Dec 21, 1999 | Supplement 81Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 79Manufacturing | Approved | None posted |
| May 13, 1999 | Supplement 80Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 77Manufacturing | Approved | None posted |
| Nov 16, 1998 | Supplement 78Manufacturing | Approved | None posted |
| Apr 16, 1997 | Supplement 76Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 75Manufacturing | Approved | None posted |
| Aug 2, 1993 | Supplement 74Labeling | Approved | None posted |
| May 1, 1992 | Supplement 70Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 73Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 71Manufacturing | Approved | None posted |
| May 10, 1989 | Supplement 69Labeling | Approved | None posted |
| Jul 17, 1987 | Supplement 67Manufacturing | Approved | None posted |
| Jul 17, 1987 | Supplement 66Manufacturing | Approved | None posted |
| Mar 20, 1987 | Supplement 65Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 60Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 59Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 58Manufacturing | Approved | None posted |
| Nov 12, 1985 | Supplement 57Manufacturing | Approved | None posted |
| Jun 7, 1982 | Supplement 39Manufacturing | Approved | None posted |
| Jun 10, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters